Beyond insulin: advancing frontiers in cell-based and genetic therapies for type 1 diabetes management
Abstract Background Type 1 diabetes (T1D) is a chronic autoimmune disorder resulting in the destruction of pancreatic beta cells, leading to absolute insulin deficiency. Despite advances in exogenous insulin therapy, patients continue to face significant challenges, including glycemic variability, r...
Saved in:
| Main Author: | Tamer A. Addissouky |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-06-01
|
| Series: | The Egyptian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43162-025-00477-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Last Mile in Beta-Cell Replacement Therapy for Type 1 Diabetes: Time to Grow Up
by: Lorenzo Piemonti, et al.
Published: (2025-04-01) -
One-year evaluation of automated insulin delivery systems in adults with type 1 diabetes
by: Pedro Pujante, et al.
Published: (2025-07-01) -
Genetic framework of type 2 diabetes mellitus
by: Irina Arkad'evna Bondar', et al.
Published: (2013-12-01) -
Determination and analysis of the gene expression, involved in the differentiation and functioning of beta cells under the conditions of the development of experimental diabetes of the dexamethasone type (type 2 diabetes)
by: T. V. Ivanenko, et al.
Published: (2025-03-01) -
Microfluidic chip systems for characterizing glucose-responsive insulin-secreting cells equipped with FailSafe kill-switch
by: Mohammad Izadifar, et al.
Published: (2024-12-01)